Madrigal Pharmaceuticals, Inc. (MDGL)

432.83 -6.51 (-1.48%) USD  |  NASDAQ  |  Mar 06, 16:00
430.20 -2.63 (-0.61%) Pre-Market: 20:00
More

Madrigal Pharmaceuticals Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Eli Lilly & Co. Upgrade
Johnson & Johnson Upgrade